https://www.trialx.com/clinical-trials/listings/288976/a-study-to-evaluate-465/?&geo_lat=53.2193835&geo_lng=6.5665017&radius=10&place=Groningen&user_country=Netherlands
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With...
Clinical trial for Recurrent or Metastatic Solid Tumors , A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With...
a studyifinatamab deruxtecanevaluateefficacysafety
https://daiichisankyo.us/en/press-releases/-/article/ifinatamab-deruxtecan-granted-breakthrough-therapy-designation-by-us-fda-for-patients-with-pretreated-extensive-stage-small-cell-lung-cancer
Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with...
Read and download our press releases.
ifinatamab deruxtecanbreakthrough therapyfor patientsgranteddesignation
https://www.merckclinicaltrials.com/trial/nct06863272/?lang=en-ca
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat...
Sep 22, 2026 - The purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with...
clinical studyifinatamab deruxtecanbasedtreatmentcombinations